Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL945241 | 0.79 | CA14 (0.35) | — | |
| SCHEMBL21131771 | 0.78 | KDM4E (0.30) | — | |
| SCHEMBL14474311 | 0.76 | PHF8 (0.31) | — | |
| SCHEMBL18965258 | 0.76 | MEN1 (0.34) | ALDH1A1MEN1KMT2A | |
| SCHEMBL4638213 | 0.74 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL21286081 | 0.72 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL7048627 | 0.72 | MEN1 (0.35) | CA2MEN1KMT2A | |
| SCHEMBL19379975 | 0.72 | PHF8 (0.32) | — | |
| SCHEMBL14343085 | 0.72 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL31121301 | 0.71 | SMN1; SMN2 (0.48) | ALDH1A1POLBSMN1; SMN2CA2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140023592-A1 | SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS | RWTH AACHEN (DE) | 2014-01-23 | — | — | US | disclosed |
| EP-2587263-A1 | Self coupling recombinant antibody fusion proteins | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2013-05-01 | — | — | EP | disclosed |
| US-20110014216-A1 | Drug Transfer Based on Coenzyme A and Acyl Carrier Protein | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014216-A1 | Drug Transfer Based on Coenzyme A and Acyl Carrier Protein | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014196-A1 | Drug Transfer into Living Cells | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014196-A1 | Drug Transfer into Living Cells | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014196-A1 | Drug Transfer into Living Cells | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20110014216-A1 | Drug Transfer Based on Coenzyme A and Acyl Carrier Protein | COVALYS BIOSCIENCES AG (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20100183516-A1 | SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110014196-A1 | Drug Transfer into Living Cells | TSPO, MPI, ABCB1 | ALDH1A1 1179/4885POLB 3741/4885SMN1; SMN2 2482/4885 |
| US-20110014216-A1 | Drug Transfer Based on Coenzyme A and Acyl Carrier Protein | COASY, ACAT2, ACAT1 | ALDH1A1 736/4885POLB 4629/4885SMN1; SMN2 4649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.